Penn researchers find treatment for MS also reduces vision loss in ...
EurekAlert (press release) - Washington,DC,USA
... researchers at the University of Pennsylvania
School of Medicine have found that natalizumab
(TYSABRI®) – a drug that slows disability and reduces ...
See all stories on this topic

MS Patients Not Getting Drugs to Slow Disease Progression ...
DG News - USA
... interferon-1a (Avonex), glatiramer acetate
(GA or Copaxone), interferon-1a (Rebif),
mitoxantrone (Novantrone) and natalizumab (Tysabri). ...
See all stories on this topic